Warby Parker Inc.

NYSE:WRBY

Medical - Instruments & Supplies

Healthcare
$28.22 +3.78%

+$0.92 today

Market cap
$3.07B
Beta
1.97
P/E (TTM)
2305.1
EPS (TTM)
$0.01
52W Low $14.96High $31.00

Volume 5.90M

Average 2.81M

WRBY EBITDA Margin

EBITDA as a percentage of revenue.

Warby Parker Inc.NYSE: WRBY

EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026

EBITDA Margin widens to 8.2%

EBITDA Margin was 8.2% in Q2 FY2026, up 3.6 pp from a year earlier. On a trailing-twelve-month basis it was 7.0%, up 2.0 pp year over year. Over 3 fiscal years it widened by 19.2 pp.

Context

  • EBITDA Margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 10 analysts of 12.0% for the fiscal year ending Dec 2026, up from 6.1% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
8.2%+0.9 pp QoQ
Last fiscal yearDec 2025
6.1%+2.7 pp YoY
LTMJun 2026
7.0%+2.0 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+3.6 pp+3.0 pp-0.6 pp
1 year+2.7 pp+5.9 pp+3.2 pp
3 years+19.2 pp+6.9 pp-12.3 pp
5 years+9.7 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
6.1%
Year-over-year change
+2.7pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How WRBY compares with its peers on the latest reported figures

  • WRBY's LTM Jun 2026 EBITDA Margin of 7.0% is the 7th highest of the 10 companies compared; the peer median is 17.0%.
  • Its year-over-year change of +2.0 pp is the 4th highest of 10, against a peer median of +0.5 pp.
  • Over three fiscal years its change of +19.2 pp compares with a peer median of -0.2 pp.
WRBY Competitors Peer median
EBITDA Margin for WRBY and competitors
Company Period LTM level YoY 3-year change
LMATLeMaitre Vascular, Inc.LTM Mar 202637.6% +5.3 pp+13.5 pp
CONConcentra Group Holdings Parent, Inc.LTM Sep 202620.5% +1.3 pp-0.2 pp
HAEHaemonetics CorporationLTM Jun 202619.3% -8.7 pp-2.2 pp
BHCBausch Health Companies Inc.LTM Jun 202618.9% -14.3 pp-4.5 pp
ITGRInteger Holdings CorporationLTM Jul 202617.0% +0.5 pp-0.6 pp
ICUIICU Medical, Inc.LTM Jun 202611.5% -2.1 pp+5.5 pp
WRBYWarby Parker Inc.LTM Jun 20267.0% +2.0 pp+19.2 pp
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026-3.5% +10.1 pp+15.6 pp
QDELQuidelOrtho CorporationLTM Mar 2026-20.7% -31.1 pp-51.4 pp
BEAMBeam Therapeutics Inc.LTM Jun 2026-40.5% +584.3 pp+435.7 pp
Peer median (excluding WRBY) 17.0%+0.5 pp-0.2 pp

Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue540.8M598.11M669.77M771.32M871.91M
Cost of Revenue223.05M257.05M304.54M344.48M401.33M
Gross Profit317.75M341.06M365.22M426.83M470.58M
Gross Margin58.8%57.0%54.5%55.3%54.0%
Research & Development00000
Selling, General & Admin461.41M452.27M421.57M440.05M475.92M
Operating Expenses461.41M452.27M437.22M456.95M475.92M
Depreciation & Amortization21.87M31.86M38.55M45.87M50.28M
EBITDA(122.14M)(78.03M)(24.21M)26.35M53.32M
EBITDA Margin-22.6%-13.0%-3.6%3.4%6.1%
Operating Income(143.66M)(111.2M)(72M)(30.11M)(5.34M)
Operating Margin-26.6%-18.6%-10.7%-3.9%-0.6%
Interest Income01.31M9.23M10.6M8.38M
Interest Expense347K0000
Other Income / Expenses(347K)1.31M9.23M10.6M8.38M
Income Before Tax(144.01M)(109.9M)(62.76M)(19.52M)3.04M
Pre-Tax Margin-26.6%-18.4%-9.4%-2.5%0.3%
Income Tax Expense263K497K433K875K1.4M
Net Income(144.27M)(110.39M)(63.2M)(20.39M)1.64M
Net Margin-26.7%-18.5%-9.4%-2.6%0.2%
EPS (Basic)(1.39)(0.96)(0.54)(0.17)0.01
EPS (Diluted)(1.39)(0.96)(0.54)(0.17)0.01
Weighted Avg Shares113.62M114.94M117.39M120.39M122.67M
Weighted Avg Shares (Diluted)113.62M114.94M117.39M120.39M125.1M

Warby Parker Inc.

NYSE:WRBY

Intrinsic Alpha fair value

Locked

Current Price

$28.22

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.